We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Tells Devicemakers to Balance Risk With Need to Show Efficacy
MHRA Tells Devicemakers to Balance Risk With Need to Show Efficacy
Medtech sponsors should balance the need to demonstrate safety and efficacy with the potential risks to patients when determining the size and duration of a clinical trial, a new guidance by the UK’s Medicines and Healthcare products Regulatory Agency says.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor